Organon & Co. Common Stock vs SMX Security Matters plc — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while SMX Security Matters plc trades at $3.86 (market cap $4.09M). The key difference: Organon & Co. Common Stock is far larger — about 885.1× SMX Security Matters plc's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and SMX Security Matters plc for 22 Days on average.
| OGN | SMX | |
|---|---|---|
Market Cap | $3.62B | $4.09M |
Volume | 2,892,999 | 108,612 |
Sector | Health | Industrials |
52-Week High | $13.81 | $74.08K |
52-Week Low | $5.70 | $3.56 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $11.04B | -$27.23M |
Dividend Yield | 0.58% | — |
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
SMX stock trades at $3.79, up 4.7% today, but faces severe fundamental challenges with no revenue reported for 2025 and a net loss of $169.18 million. The technical outlook is bearish based on moving averages, though oversold oscillators suggest potential for a near-term bounce. The company is actively promoting its Digital Material Passport technology for recycling and material verification, generating significant media coverage in outlets like Forbes and TIME as of late September 2026.
The investment case is highly speculative. While the company's technology narrative is gaining media traction, the absence of revenue and deeply negative profitability metrics present substantial risk. Investor optimism appears driven by the long-term potential of its circular economy platform rather than current financial performance, making the stock suitable only for risk-tolerant investors betting on a successful business turnaround.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →